Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.7 (
acetylcholinesterase
)
28,390
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
acetylcholinesterase
(
AChE
) and butyrylcholinesterase (BChE) activities in the neural retina and retinal pigment epithelium (RPE) of adult rats were determined. The tissues were extracted with a saline buffer to release the soluble enzymes (S1) and the pellet re-extracted with Triton X-100 to detach the membrane-bound enzymes (S2). Less than 5% of the
cholinesterase
activity measured in retina and almost 30% of that assayed in RPE was due to BChE. About 20% and 10% of the
AChE
in retina and RPE was brought into solution with a saline buffer and the rest with a detergent-containing buffer. Main
AChE
molecular forms of 10.5S (hydrophilic G4H), 9.5S (amphiphilic G4A) and 3.0S (amphiphilic G1A) were identified in retina by subjecting the supernatant S1 to sedimentation analysis in sucrose gradients made with Brij 96. Amphiphilic G4 and G1
AChE
were found in S2. Analysis of the soluble fractions obtained from RPE in the gradients made with Brij 96 revealed 16.0S (asymmetric A12), 10.5-10.0S (globular G4H + G4A), 4.5S (
G2A
), and 3.0S (G1A)
AChE
forms in S1, whereas G4A,
G2A
, and G1A enzyme molecules predominated in S2. Our results show that amphiphilic tetramers and monomers of
AChE
are abundant in neural retina, and enzyme tetramers, dimers, and monomers in RPE. The
AChE
in the neural retina might be involved in cholinergic actions. The enzyme function in the retinal pigment epithelium remains to be established.
...
PMID:Acetyl- and butyrylcholinesterase activities in the rat retina and retinal pigment epithelium. 756 46
In searching for possible differences in the composition of
acetylcholinesterase
(
AChE
) and butyrylcholinesterase (BuChE) forms in dystrophic brain, the distribution of various enzyme molecules in normal (NB) and dystrophic (DB) 129B6F1/J mouse brain has been investigated. The tissue was sequentially extracted with saline (S1) and with saline-Triton X-100 buffers (S2) to release soluble and membrane-bound cholinesterases. About 15% of the
AChE
and 35% of the BuChE activities in NB were recovered in S1, and the rest in S2. G4, G2, and G1
AChE
and BuChE forms were identified in the soluble fractions obtained from NB and DB. The shift in sedimentation values of the separated
AChE
and BuChE species in sucrose gradients made with and without detergents revealed the occurrence of hydrophilic (H) and amphiphilic (A) variants of cholinesterases in the extracts. The amphiphilic properties of the several
AChE
and BuChE molecules were analyzed by Triton X-114 phase-partitioning and by phenyl-agarose chromatography. A12 (1%), G4A (72%), G4H (8%), and
G2A
+ G1A (19%)
AChE
molecules, and G4A (34%), G4H (19%), and
G2A
+ G1A (47%) BuChE forms, were identified in NB. The G4A
AChE
and BuChE isoforms differed in their interaction with Triton X-114 and with a hydrophobic matrix. Neither the extent of
cholinesterase
solubilization, nor the distribution of individual enzyme forms, was significantly altered in DB. The lack of specific differences in the distribution of
AChE
and BuChE forms between NB and DB suggests that the biosynthetic pathway leading to the various enzyme forms is altered in muscle but not in dystrophic mouse brain.
...
PMID:Molecular forms of acetyl- and butyrylcholinesterase in normal and dystrophic mouse brain. 882 Sep 70
The distribution and glycosylation of
acetylcholinesterase
(
AChE
) forms in vesicles derived from sarcoplasmic reticulum of normal muscle (NMV) were investigated and compared with those from dystrophic muscle vesicles (DMV).
AChE
activity was similar in NMV and DMV. Most of the
AChE
in NMV and half in DMV were released with Triton X-100. Asymmetric (A12) and globular hydrophilic and amphiphilic (G4H, G4A,
G2A
, and G1A)
AChE
species occurred in NMV and DMV, the lighter forms being predominant. The percentage of G4H and G4A decreased in DMV. A fraction of the
AChE
that could not be extracted with detergent was detached with collagenase. Most of the detergent-released A12
AChE
from NMV and nearly half in DMV failed to bind to Ricinus communis agglutinin (RCA-I). Conversely, the collagenase-detached isoforms bound to RCA, revealing that asymmetric
AChE
associated with internal membranes or basal lamina differed in glycosylation. Moreover, nearly half of G4A
AChE
in DMV and a few in NMV bound to RCA. Most of the RCA-unreactive G4A forms in NMV come from sarcolemma. The results indicate that dystrophy induces minor changes in the distribution and glycosylation of
AChE
forms in internal membranes of muscle.
...
PMID:Glycosylation of acetylcholinesterase forms in microsomal membranes from normal and dystrophic Lama2dy mouse muscle. 934 41
Because of the probable involvement of cholinesterases (ChEs) in tumorigenesis, this research was addressed to ascertaining whether breast cancer metastasis alters the content of
acetylcholinesterase
(
AChE
) and/or butyrylcholinesterase (BuChE) in axillary lymph nodes (LN). ChE activity was assayed in nine normal (NLN) and seven metastasis-bearing nodes (MLN) from women.
AChE
and BuChE forms were characterised by sedimentation analyses, hydrophobic chromatography and western blotting. The origin of ChEs in LN was studied by lectin interaction.
AChE
activity dropped from 21.6 mU/mg (nmol of the substrate hydrolysed per minute and per milligram protein) in NLN to 3.8 mU/mg in MLN (p < 0.001), while BuChE activity (3.6 mU/mg) was little affected. NLN contained globular amphiphilic
AChE
dimers (
G2A
, 35%), monomers (G1A, 30%), hydrophilic tetramers (G4H, 8%), and asymmetric species (A4, 23%, and A8, 4%); MLN displayed only
G2A
(65%) and G1A (35%)
AChE
forms. NLN and MLN contained G4H (79%), G4A (7%), and G1H (14%) BuChE components. Neither the binding of ChE forms with lectins and antibodies nor the subunit size were altered by metastasis. The higher level of
AChE
in NLN than in brain and the specific pattern of
AChE
forms in NLN support its role in immunity. The different profile of
AChE
forms in NLN and MLN may be useful for diagnosis.
...
PMID:Breast cancer metastasis alters acetylcholinesterase activity and the composition of enzyme forms in axillary lymph nodes. 1288 4
The presence of
acetylcholinesterase
(
AChE
) mRNA and activity in the tissues and cells involved in immune responses prompted us to investigate the level and pattern of
AChE
components in spleen.
AChE
activity was higher in mouse spleen (0.46 +/- 0.13 micromol of acetylthiocholine split per hour and per mg protein) than in muscle or heart, but lower than in brain. The spleen was essentially free of butyrylcholinesterase (BuChE) activity. About 40% of spleen
AChE
was extracted with a saline buffer, and a further 40% with 1% Triton X-100. Sedimentation analyses, the splitting of subunits in
AChE
dimers, phosphatidylinositol-specific phospholipase C (PIPLC) exposure, and phenyl-agarose chromatography showed that hydrophilic (G1H, 43%) and amphiphilic
AChE
monomers (G1A, 36%), as well as amphiphilic dimers (
G2A
, 21%), occurred in spleen. All these molecules bound to fasciculin-2-Sepharose, although the extent of binding was higher for G1H (77%) than for G1A (63%) or
G2A
(48%) forms. Differences in the extent to which wheat germ lectin (WGA) adsorbed with
AChE
of mouse spleen and of erythrocyte allowed us to discard the blood origin of spleen
AChE
activity. A 62 kDa protein was labeled in spleen samples using antibodies against human
AChE
. The protein was attributed to
AChE
monomers since its size was the same, regardless of whether disulfide bonds were reduced or not. Since cholinergic stimulation modulates proliferation/maturation of lymphoid cells,
AChE
may be important for regulating the level of acetylcholine (ACh) in the neighborhood of cholinergic receptors (AChR) in spleen and other lymphoid tissues.
...
PMID:Molecular properties of acetylcholinesterase in mouse spleen. 1508 30
Half of congenital muscular dystrophy cases arise from laminin alpha2 (merosin) deficiency, and merosin-deficient mice (Lama2dy) exhibit a dystrophic phenotype. The abnormal development of thymus in Lama2dy mice, the occurrence of
acetylcholinesterase
(
AChE
) in the gland and the impaired distribution of
AChE
molecules in skeletal muscle of the mouse mutant prompted us to compare the levels of
AChE
mRNAs and enzyme species in thymus of control and Lama2dy mice.
AChE
activity in normal thymus (mean +/- SD 1.42 +/- 0.28 micromol acetylthiocholine/h/mg protein, U/mg) was decreased by approximately 50% in dystrophic thymus (0.77 +/- 0.23 U/mg) (p = 0.007), whereas butyrylcholinesterase activity was little affected. RT-PCR assays revealed variable levels of R, H and T
AChE
mRNAs in thymus, bone marrow and spinal cord. Control thymus contained amphiphilic
AChE
dimers (
G2A
, 64%) and monomers (G1A, 19%), as well as hydrophilic tetramers (G4H, 9%) and monomers (G1H, 8%). The dimers consisted of glycosylphosphatidylinositol-anchored H subunits. Western blot assays with anti-
AChE
antibodies suggested the occurrence of inactive
AChE
in mouse thymus. Despite the decrease in
AChE
activity in Lama2dy thymus, no differences between thymuses from control and dystrophic mice were observed in the distribution of
AChE
forms, phosphatidylinositol-specific phospholipase C sensitivity, binding to lectins and size of
AChE
subunits.
...
PMID:Muscular dystrophy by merosin deficiency decreases acetylcholinesterase activity in thymus of Lama2dy mice. 1613 75